These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22491199)

  • 41. Skeletal muscle metabolism is impaired during exercise in glycogen storage disease type III.
    Preisler N; Laforêt P; Madsen KL; Prahm KP; Hedermann G; Vissing CR; Galbo H; Vissing J
    Neurology; 2015 Apr; 84(17):1767-71. PubMed ID: 25832663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incomplete palmitate oxidation. Possible source of human myopathy.
    Shumate JB; Brooke MH; Carroll JE; Choksi RM
    Arch Neurol; 1982 Sep; 39(9):561-4. PubMed ID: 7115144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients.
    Pennisi EM; Arca M; Bertini E; Bruno C; Cassandrini D; D'amico A; Garibaldi M; Gragnani F; Maggi L; Massa R; Missaglia S; Morandi L; Musumeci O; Pegoraro E; Rastelli E; Santorelli FM; Tasca E; Tavian D; Toscano A; Angelini C;
    Orphanet J Rare Dis; 2017 May; 12(1):90. PubMed ID: 28499397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muscle MRI in neutral lipid storage disease with myopathy carrying mutation c.187+1G>A.
    Xu C; Zhao Y; Liu J; Zhang W; Wang Z; Yuan Y
    Muscle Nerve; 2015 Jun; 51(6):922-7. PubMed ID: 25363365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The anesthetic management of a patient with Dorfman-Chanarin syndrome.
    Beştaş A; Bolat E; Bayar MK; Erhan OL
    Middle East J Anaesthesiol; 2011 Oct; 21(3):437-40. PubMed ID: 22428507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disorders of lipid metabolism in skeletal muscle.
    Cwik VA
    Neurol Clin; 2000 Feb; 18(1):167-84. PubMed ID: 10658173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of familial idiopathic lipid storage myopathy with L-carnitine and modified lipid diet.
    Snyder TM; Little BW; Roman-Campos G; McQuillen JB
    Neurology; 1982 Oct; 32(10):1106-15. PubMed ID: 6889698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant.
    Latimer CS; Schleit J; Reynolds A; Marshall DA; Podemski B; Wang LH; Gonzalez-Cuyar LF
    Neuromuscul Disord; 2018 Jul; 28(7):606-609. PubMed ID: 29779757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutral lipid storage disease with ichthyosis: lipid content and metabolism of fibroblasts.
    Williams ML; Monger DJ; Rutherford SL; Hincenbergs M; Rehfeld SJ; Grunfeld C
    J Inherit Metab Dis; 1988; 11(2):131-43. PubMed ID: 3139924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early onset neutral lipid storage disease with myopathy presenting as congenital hypotonia and hepatomegaly.
    Avila-Smirnow D; Durán-Saavedra G; Ovalle-Besa P; Gejman-Enríquez R
    Neuromuscul Disord; 2021 Jan; 31(1):52-55. PubMed ID: 33303358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy.
    Ash DB; Papadimitriou D; Hays AP; Dimauro S; Hirano M
    Arch Neurol; 2012 Sep; 69(9):1190-2. PubMed ID: 22964912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dorfman-Chanarin syndrome: morphologic studies and presentation of new cases.
    Srebrnik A; Brenner S; Ilie B; Messer G
    Am J Dermatopathol; 1998 Feb; 20(1):79-85. PubMed ID: 9504676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Muscle symptoms and fat oxidation.
    Lancet; 1970 May; 1(7656):1096. PubMed ID: 4191970
    [No Abstract]   [Full Text] [Related]  

  • 54. The regulation of glucose uptake and oxidation during exercise.
    Kelley DE
    Int J Obes Relat Metab Disord; 1995 Oct; 19 Suppl 4():S14-7. PubMed ID: 8581089
    [No Abstract]   [Full Text] [Related]  

  • 55. Substrate competition in glucose and palmitate oxidation in the intact rat.
    LEWIS KF; ALLEN A; WEINHOUSE S
    Arch Biochem Biophys; 1959 Dec; 85():499-511. PubMed ID: 14416542
    [No Abstract]   [Full Text] [Related]  

  • 56. Muscle MRI in neutral lipid storage disease (NLSD).
    Garibaldi M; Tasca G; Diaz-Manera J; Ottaviani P; Laschena F; Pantoli D; Gerevini S; Fiorillo C; Maggi L; Tasca E; D'Amico A; Musumeci O; Toscano A; Bruno C; Massa R; Angelini C; Bertini E; Antonini G; Pennisi EM
    J Neurol; 2017 Jul; 264(7):1334-1342. PubMed ID: 28503705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Refractory Hyperlactatemia with Organ Insufficiency in Lipid Storage Myopathy.
    Xu Y; Zhou L; Liang W; He W; Liu X; Liang X; Zhong N; Li Y
    Arch Iran Med; 2015 Aug; 18(8):545-8. PubMed ID: 26265524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis-associated lipid storage myopathy.
    Patten BM; Shabot JM; Alperin J; Dodson RF
    Ann Intern Med; 1977 Oct; 87(4):417-21. PubMed ID: 907240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of lipid metabolism during exercise.
    Sidossis LS
    World Rev Nutr Diet; 2001; 90():44-54. PubMed ID: 11545044
    [No Abstract]   [Full Text] [Related]  

  • 60. Neutral lipid storage disease. Case report and lipid studies.
    Judge MR; Atherton DJ; Salvayre R; Hilaire N; Levade T; Johnston DI; Winchester B; Lake BD
    Br J Dermatol; 1994 Apr; 130(4):507-10. PubMed ID: 8186119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.